Atlas Trials

The Effects of Hemodialysis on Serum Sclerostin Levels

Clinical trial NCT03952819 · COMPLETED

Trial details

NCT number
NCT03952819
Sponsor
Abant Izzet Baysal University
Status
COMPLETED
Study type
OBSERVATIONAL
Diabetes MellitusRenal FailureHemodialysis Access Failure
Start date
2017-09-14
Primary completion
2018-11-15
Enrollment
56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.